ADIO drives growth across priority sectors that align with Abu Dhabi’s long-term economic vision. By focusing on areas with high growth potential and global relevance, ADIO empowers innovators, investors and entrepreneurs to unlock new value in the Emirate.
Select a Cluster
Life Sciences
A fast-growing healthcare and biopharma sector, supported by significant government investment and advanced medical infrastructure, makes the emirate an emerging hub for life sciences. The region’s commitment to cutting-edge healthcare technologies, medical research, and world-class facilities has created a thriving environment for innovation in diagnostics, therapeutics, biotech, and biopharma manufacturing.
Ongoing collaborations with leading international healthcare providers and research institutions further strengthen the life sciences ecosystem, while policies enabling 100% foreign ownership and initiatives like the HELM Cluster (Health, Endurance, Longevity, and Medicine), Abu Dhabi’s fully integrated life sciences hub, make it an attractive destination for global life sciences companies.
Highlights
An average 28-day clinical trial approval timeline and strong IP protections.
Home to one of the world’s largest genomics initiatives with the Emirati Genome Programme with over 650,000 genomic samples.
100% foreign ownership permitted for hospitals, clinics, and life sciences ventures.
Robust government-backed investment and R&D partnerships.